Stay updated with breaking news from Zusz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR ... | April 11, 2021
For the rich, living in Asia is costlier than anywhere else.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel ... AKAMPIONApril 12, 2021 GMT - Company forms international consortium with ProteoGenix SAS and Amsterdam UMC Schlieren (Zurich Area), Switzerland – April 12, 2021 – ImmunOs Therapeutics AG, a Swiss bio-technology company developing a new class of biologics for the treatment of cancer and autoimmune diseases, announced today that is has received public funding from the European Union’s Eurostars-2 Progra...
Delivering Paris Agreement could help save most endangered species, report reveals More than nine in ten plant and animal species will face challenges if the current global warming trajectory continues, a new study has revealed. But most species could be saved from extinction if the world delivers on the Paris Agreement. Tropical forests and islands, as well as mountains, are facing higher extinction risks than the global average, according to the paper Published in the Biological Conservation journal late last week and including research from teams across Europe, New Zealand, the Caribbean a...
HEALTH-CORONAVIRUS/ROCHE-REGENERON PHARMS (UPDATE 2):UPDATE 2-Regeneron to seek U.S. OK for COVID-19 cocktail to be used for prevention